Company Filing History:
Years Active: 2018
Title: Matthias Paetzold: Innovator in Medical Device Technology
Introduction
Matthias Paetzold is a prominent inventor based in Melsungen, Germany. He has made significant contributions to the field of medical technology, particularly in the area of data transmission and blood parameter monitoring. With a total of 2 patents, his work has the potential to enhance the efficiency and effectiveness of medical devices.
Latest Patents
Paetzold's latest patents include a "System and method for controlling a data transmission to and/or from a plurality of medical devices." This invention focuses on a system that manages data transmission among various medical devices, organized into groups. Each group connects to a communication device that interacts with a central server for data storage and control.
Another notable patent is the "System and method for monitoring time intervals during blood parameter monitoring." This system involves multiple access devices that allow for blood sampling from patients, along with analysis devices that evaluate blood parameters. The calculated data sets assist in determining the appropriate drug parameters for each patient.
Career Highlights
Matthias Paetzold is associated with B. Braun Melsungen AG, a leading company in the medical technology sector. His work at B. Braun has allowed him to focus on innovative solutions that address critical healthcare challenges. His inventions reflect a commitment to improving patient care through advanced technology.
Collaborations
Throughout his career, Paetzold has collaborated with notable colleagues, including Horst Schmoll and Hans-Otto Maier. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge medical solutions.
Conclusion
Matthias Paetzold stands out as a key figure in the realm of medical device innovation. His patents demonstrate a dedication to enhancing medical technology and improving patient outcomes. His contributions are likely to have a lasting impact on the healthcare industry.